News
This startup’s mission to extend human life sounds like sci-fi, and investors are betting $20M on it
Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results